Screener
Artiva Biotherapeutics, Inc. ARTV Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Artiva Biotherapeutics, Inc.’s 10-K, filed March 10, 2026.
- Filed
- Mar 10, 2026, 4:09 PM EDT
- Fiscal year
- FY2025
- Accession
- 0001193125-26-100135
| Line item | AS OF / DECEMBER 31,2025 | AS OF / DECEMBER 31,2024 |
|---|---|---|
| Commitments and contingencies (Note 10) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized at December 31, 2025 and December 31, 2024; zero shares issued and outstanding as of December 31, 2025 and December 31, 2024 | — | — |
| Common stock, $0.0001 par value; 700,000,000 shares authorized at December 31, 2025 and December 31, 2024; 24,595,550 and 24,291,607 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 3 | 3 |
| Additional paid-in capital | 440,413 | 433,451 |
| Accumulated other comprehensive income (loss) | 103 | (129) |
| Accumulated deficit | (330,549) | (246,684) |
| Total stockholders’ equity | 109,970 | 186,641 |
Item 16. Form 10-K Summary
FAQ
- What is Artiva Biotherapeutics, Inc.'s common stock?
- Artiva Biotherapeutics, Inc. (ARTV) reported common stock of 3K in Q4 2025.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Artiva Biotherapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude